Baidu
map

Obesity Surgery:减肥手术后口味会改变?

2014-04-23 佚名 和讯网

英国一项最新研究发现,进行了胃旁路手术这一减肥手术的患者,他们的胃口、口味和嗅觉都会发生改变。 胃旁路手术是治疗病态肥胖症的一种方法,简单说就是缩小胃、缩短小肠,改变食物经过消化道的途径,减缓胃排空速度、降低吸收。 英国研究人员在最新一期《肥胖症手术》杂志网络版上报告说,他们对 103 名接受胃旁路手术的英国人进行了调查,其中 97% 的人表示其食欲在手术后明显改变,42% 的人表示自己嗅觉的

英国一项最新研究发现,进行了胃旁路手术这一减肥手术的患者,他们的胃口、口味和嗅觉都会发生改变。

胃旁路手术是治疗病态肥胖症的一种方法,简单说就是缩小胃、缩短小肠,改变食物经过消化道的途径,减缓胃排空速度、降低吸收。

英国研究人员在最新一期《肥胖症手术》杂志网络版上报告说,他们对 103 名接受胃旁路手术的英国人进行了调查,其中 97% 的人表示其食欲在手术后明显改变,42% 的人表示自己嗅觉的灵敏度下降。此外,73% 的人对食物的口味也在手术后发生了改变,尤其是对酸味和甜味的习惯发生改变。

有趣的是,近四分之三的患者在接受胃旁路手术后不再喜欢吃肉了,12% 的患者对米饭、意式面条、面包等淀粉类食物的喜好发生了逆转,对蔬菜和水果喜好发生改变的患者比例只有 4% 和 3%。

研究人员表示,患者手术后嗅觉、口味改变可能是因为肠道激素水平发生变化,以及手术对中枢神经系统造成的影响,医生在手术前会将这些情况告诉患者。

原始出处:

L. Graham, G. Murty, D. J. Bowrey. Taste, Smell and Appetite Change After Roux-en-Y Gastric Bypass Surgery. Obesity Surgery, March 2014; DOI:10.1007/s11695-014-1221-2

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1910461, encodeId=ad61191046147, content=<a href='/topic/show?id=faf7163606a' target=_blank style='color:#2F92EE;'>#SIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16360, encryptionId=faf7163606a, topicName=SIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Mon Jun 09 09:31:00 CST 2014, time=2014-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877658, encodeId=ff1518e7658d3, content=<a href='/topic/show?id=b013169237f' target=_blank style='color:#2F92EE;'>#surgery#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16923, encryptionId=b013169237f, topicName=surgery)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sat Jan 31 00:31:00 CST 2015, time=2015-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021479, encodeId=8e9020214e9b2, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Oct 20 14:31:00 CST 2014, time=2014-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461725, encodeId=16281461e2527, content=<a href='/topic/show?id=92c2132003b' target=_blank style='color:#2F92EE;'>#Obesity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13200, encryptionId=92c2132003b, topicName=Obesity)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45616444603, createdName=lingaifan, createdTime=Fri Apr 25 00:31:00 CST 2014, time=2014-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588156, encodeId=75c415881568c, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Fri Apr 25 00:31:00 CST 2014, time=2014-04-25, status=1, ipAttribution=)]
    2014-06-09 智慧医人
  2. [GetPortalCommentsPageByObjectIdResponse(id=1910461, encodeId=ad61191046147, content=<a href='/topic/show?id=faf7163606a' target=_blank style='color:#2F92EE;'>#SIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16360, encryptionId=faf7163606a, topicName=SIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Mon Jun 09 09:31:00 CST 2014, time=2014-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877658, encodeId=ff1518e7658d3, content=<a href='/topic/show?id=b013169237f' target=_blank style='color:#2F92EE;'>#surgery#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16923, encryptionId=b013169237f, topicName=surgery)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sat Jan 31 00:31:00 CST 2015, time=2015-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021479, encodeId=8e9020214e9b2, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Oct 20 14:31:00 CST 2014, time=2014-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461725, encodeId=16281461e2527, content=<a href='/topic/show?id=92c2132003b' target=_blank style='color:#2F92EE;'>#Obesity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13200, encryptionId=92c2132003b, topicName=Obesity)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45616444603, createdName=lingaifan, createdTime=Fri Apr 25 00:31:00 CST 2014, time=2014-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588156, encodeId=75c415881568c, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Fri Apr 25 00:31:00 CST 2014, time=2014-04-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1910461, encodeId=ad61191046147, content=<a href='/topic/show?id=faf7163606a' target=_blank style='color:#2F92EE;'>#SIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16360, encryptionId=faf7163606a, topicName=SIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Mon Jun 09 09:31:00 CST 2014, time=2014-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877658, encodeId=ff1518e7658d3, content=<a href='/topic/show?id=b013169237f' target=_blank style='color:#2F92EE;'>#surgery#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16923, encryptionId=b013169237f, topicName=surgery)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sat Jan 31 00:31:00 CST 2015, time=2015-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021479, encodeId=8e9020214e9b2, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Oct 20 14:31:00 CST 2014, time=2014-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461725, encodeId=16281461e2527, content=<a href='/topic/show?id=92c2132003b' target=_blank style='color:#2F92EE;'>#Obesity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13200, encryptionId=92c2132003b, topicName=Obesity)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45616444603, createdName=lingaifan, createdTime=Fri Apr 25 00:31:00 CST 2014, time=2014-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588156, encodeId=75c415881568c, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Fri Apr 25 00:31:00 CST 2014, time=2014-04-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1910461, encodeId=ad61191046147, content=<a href='/topic/show?id=faf7163606a' target=_blank style='color:#2F92EE;'>#SIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16360, encryptionId=faf7163606a, topicName=SIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Mon Jun 09 09:31:00 CST 2014, time=2014-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877658, encodeId=ff1518e7658d3, content=<a href='/topic/show?id=b013169237f' target=_blank style='color:#2F92EE;'>#surgery#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16923, encryptionId=b013169237f, topicName=surgery)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sat Jan 31 00:31:00 CST 2015, time=2015-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021479, encodeId=8e9020214e9b2, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Oct 20 14:31:00 CST 2014, time=2014-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461725, encodeId=16281461e2527, content=<a href='/topic/show?id=92c2132003b' target=_blank style='color:#2F92EE;'>#Obesity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13200, encryptionId=92c2132003b, topicName=Obesity)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45616444603, createdName=lingaifan, createdTime=Fri Apr 25 00:31:00 CST 2014, time=2014-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588156, encodeId=75c415881568c, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Fri Apr 25 00:31:00 CST 2014, time=2014-04-25, status=1, ipAttribution=)]
    2014-04-25 lingaifan
  5. [GetPortalCommentsPageByObjectIdResponse(id=1910461, encodeId=ad61191046147, content=<a href='/topic/show?id=faf7163606a' target=_blank style='color:#2F92EE;'>#SIT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16360, encryptionId=faf7163606a, topicName=SIT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Mon Jun 09 09:31:00 CST 2014, time=2014-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877658, encodeId=ff1518e7658d3, content=<a href='/topic/show?id=b013169237f' target=_blank style='color:#2F92EE;'>#surgery#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16923, encryptionId=b013169237f, topicName=surgery)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sat Jan 31 00:31:00 CST 2015, time=2015-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021479, encodeId=8e9020214e9b2, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Mon Oct 20 14:31:00 CST 2014, time=2014-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1461725, encodeId=16281461e2527, content=<a href='/topic/show?id=92c2132003b' target=_blank style='color:#2F92EE;'>#Obesity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13200, encryptionId=92c2132003b, topicName=Obesity)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=45616444603, createdName=lingaifan, createdTime=Fri Apr 25 00:31:00 CST 2014, time=2014-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588156, encodeId=75c415881568c, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Fri Apr 25 00:31:00 CST 2014, time=2014-04-25, status=1, ipAttribution=)]
    2014-04-25 skhzy

相关资讯

Nat Med:哮喘药氨来呫诺——新的减肥药?

氨来呫诺主要用于哮喘和口腔溃疡的治疗,近日,研究人员发现氨来呫诺也可以用来治疗肥胖症、糖尿病以及脂肪肝。密歇根大学生命科学研究所的研究人员日前发现一种用于治疗哮喘及其它病症的非专利药物---氨来呫诺(amlexanox),同样可以用于治疗小鼠的肥胖症、糖尿病以及脂肪肝。Mary Sue Coleman生命科学研究所主任Alan Saltiel主持了该项研究,并于2013年2月10日将研究结果发表在

女性过瘦影响试管婴儿怀孕成功率

很多女性热衷减肥,但美国研究人员发现,对于想通过试管婴儿技术怀孕的女性而言,体型过瘦会降低她们以这种方式怀孕的成功率。 美国芝加哥高级生殖中心的研究人员日前报告说,他们研究了近8年来在这家机构试图借助试管婴儿技术怀孕的约2500名女性,并按照她们的BMI身高体重指数,将其分为过瘦组、正常组和肥胖组,统计她们的怀孕成功率。 统计结果显示,体重正常组女性的试管婴儿怀孕成功率为50%;肥胖组

Science:高热量食物让人“上瘾”的原因

当许多人为减肥而决定放弃好吃的高热量食物时,却发现自己已然无法抵御这些美味的诱惑,同时对低热量的健康食物毫无兴趣。 现在,中美一项最新研究表明,这可能是因为长期高热量饮食引发了类似吸食尼古丁的上瘾行为,只有继续吃高热量食物才会获得满足感。相关研究论文刊登在了近期出版的《科学》(Science)杂志上。 【原文下载】 在这项研究中,科学家比较了常规饲料与高脂饲料喂养的小鼠在摄取高热量与低热

减肥药物临床研究评价的考虑要点

作者 化药临床一部 内分泌药物审评小组 部门 化药临床一部 正文内容 摘要:随着人们生活水平的提高,肥胖成为全球性公共卫生问题。减肥药物的疗效及安全性是研究与评价的焦点。为使制药企业对减肥药物研发有系统的认 识,本文简要介绍肥胖的病因、治疗现状、减肥药物研发中存在的主要问题以及临床研究评价的考虑要点,供制药企业和临床研究者参考。 肥胖是病因复 杂的慢性疾病,与生理、遗传、饮食、

Cell Metabolism:运动减肥新解:白色脂肪组织变成褐色脂肪组织

    国际顶尖学术期刊Cell Metabolism就公布了有关“运动减肥”的一项最新发现,通过运动可以使白色脂肪组织(WAT)转变成褐色脂肪组织(BAT)。其实,早在两年 前,Nature就曾发文介绍过将运动与减肥相联系的蛋白质因子。这次发现之所以“新”,是因为它发现了该蛋白质因子还介导寒冷与减肥的作用,而且提及的 两个新词myokine和irisin还找不到

BMJ:儿童减肥——不仅仅是运动

英国普利茅斯大学半岛医学院的一项研究显示,“仅依靠运动来控制儿童肥胖还远远不够,必须结合饮食调整的方式,才能达到理想的效果。”近日,这一研究结果发表在《英国医学杂志》。  众所周知,运动有益于健康,而儿童肥胖,往往会对成年后心血管、内分泌等多系统造成潜在损害,针对儿童肥胖,人们往往想通过增加运动量的方式来控制患儿体重,这种看似很好的假设却通常未能取得理想的效果。为了评估锻炼干预对儿童健康

Baidu
map
Baidu
map
Baidu
map